Medtronic 2012 Annual Report Download - page 24

Download and view the complete annual report

Please find page 24 of the 2012 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 152

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152

The charts below set forth net sales of our Neuromodulation products as a percentage of our total net
sales for each of the last three fiscal years:
Customers and Competitors
The primary medical specialists who use our pain management and movement disorder products are
neurosurgeons, neurologists, pain management specialists, anesthesiologists, physiatrists, and orthopedic
spine surgeons. Our primary competitors in this business are Boston Scientific and St. Jude.
The primary medical specialists who use our gastroenterology and urology products are urologists,
urogynecologists, gastroenterologists, and colorectal surgeons. Our primary competitors in this business are
Urologix, Inc. and Allergan.
Diabetes
Our Diabetes business develops, manufactures, and markets advanced, integrated diabetes management
solutions that include insulin pump therapy, continuous glucose monitoring systems, and therapy
management software.
The following are the principal products offered by our Diabetes business:
Integrated Diabetes Management Solutions. We have the only integrated insulin pump and
continuous glucose monitoring (CGM) system in the U.S. Outside the U.S., we offer our Paradigm Veo
System, an integrated system that includes a Low Glucose Suspend feature that automatically suspends
insulin delivery when glucose levels become too low. In the U.S., we offer the Paradigm Revel System, which
incorporates new CGM features including predictive alerts that can give early warning to people with
diabetes so they can take action to prevent dangerous high or low glucose events.
Professional CGM. Medtronic offers physicians a Professional CGM product called the iPro CGM
and iPro2 Professional CGM. Physicians send patients home wearing the iPro recorder to capture glucose
data, which is later uploaded in a physician’s office to reveal glucose patterns and potential problems,
including hyperglycemic and hypoglycemic episodes, which can lead to more informed treatment decisions.
CareLink Therapy Management Software. We offer web-based therapy management software
solutions, including CareLink Personal software for patients and CareLink Pro software, to help patients and
their health care providers control their diabetes.
7
Neuromodulation
$1,700
All Other
$14,484
Fiscal Year 2012
(dollars in millions)
90%
10%
Neuromodulation
$1,592
All Other
$13,916
Fiscal Year 2011
(dollars in millions)
Neuromodulation
$1,560
All Other
$13,832
Fiscal Year 2010
(dollars in millions)
90%
10%
11%
89%